Flaskworks
Developing closed system cell culture devices for clinical manufacturing of cellular therapies.
Developing closed system cell culture devices for clinical manufacturing of cellular therapies.
Flaskworks LLC is a fully owned subsidiary of Northwest Biotherapeutics, Inc, a clinical stage biotechnology company focused on the development of personalized cancer vaccines. Flaskworks is developing closed system cell culture devices for clinical manufacturing of cellular therapies. Our technology will improve the manufacture of immuno-therapeutics and dendritic cell-based vaccines.
There is no investment information
No recent news or press coverage available for Flaskworks.
We care about your data, and we'd love to use cookies make your experience better.
